Conceptual omics image represented by many small squares in various shades of purple on a black background.
Article

Making the Most of Multiomics Data with a Single Platform

Researchers use nanopore sequencing to produce ultra-rich multiomics data for next-level human disease research.

Share

Human disease research depends on a range of multiomics approaches that researchers use to understand underlying mechanisms and advance biomarker and drug discovery. However, the need for multiple platforms to gather data leads to resource-heavy, laborious, and time-consuming workflows that may nevertheless exclude important information.

Download this brochure from Oxford Nanopore Technologies to learn how researchers use nanopore sequencing to gather ultra-rich multiomics data, maximize the information obtained from valuable tissue research samples, and resolve the molecular mechanisms of disease.

Top Image Credit:

iStock

July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery